Increasing ATP availability by inhibition of creatine kinase (CK) leakage resulting from high-intensity exercise
View Patent ↗The present invention relates to a method of increasing Adenosine Triphosphate levels in a mammal wherein 2-(carbamimidoyl-methyl-amino)ethoxyphosphonic acid inhibits the leakage of the Adenosine Triphosphate-dependant enzyme Creatine Kinase. Via the inhibition of Creatine Kinase leakage, Adenosine Triphosphate is not utilized in the conversion of creatine to phosphocreatine, thereby making it available for use in muscular contractions. The increase in availability leads to longer endurance and more forceful muscular contractions.
1. A method of reducing serum creatine kinase levels, comprising the steps of:
selecting a composition comprising fine-milled 2-(carbamimidoyl-methyl-amino)ethoxyphosphonic acid particles admixed with a comestible carrier, at least 50% of said fine-milled 2-(carbamimidoyl-methyl-amino)ethoxyphosphonic acid particles having a particle size between 2-50 nm;
orally administering to a human, following exercise, an effective amount of said composition to reduce cell rupture and increase cellular concentration of adenosine triphosphate.
2. The methods according to claim 1 , wherein at least 80% of said fine-milled 2-(carbomimidoyl-methyl-amino)ethoxyphosphic acid particles have a particle size between 2-50 nm.
3. The methods according to claim 1 , wherein at least 90% of said fine-milled 2-(carbomimidoyl-methyl-amino)ethoxyphosphic acid particles have a particle size between 2-50 nm.